When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech

Go back to When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) Delayed: 278.09 --0 (-0%)
Previous Close $278.09    52 Week High $109.10 
Open $278.09    52 Week Low $31.38 
Day High $278.09    P/E N/A 
Day Low $278.09    EPS $-1.45 
Volume 170       

AMERICAN RCT REIT (NASDAQ: ARCT) Delayed: 7.53 --0 (-0%)
Previous Close $7.53    52 Week High $13.09 
Open $7.53    52 Week Low $5.54 
Day High $7.53    P/E N/A 
Day Low $7.53    EPS $-0.38 
Volume 340       

(NASDAQ: DNLI) Delayed: 23.31 --0 (-0%)
Previous Close $23.31    52 Week High
Open $23.31    52 Week Low
Day High $23.31    P/E N/A 
Day Low $23.31    EPS
Volume 2,379       

(AMEX: OTLC) Delayed: 0.05 --0 (-0%)
Previous Close $0.05    52 Week High
Open $0.05    52 Week Low
Day High $0.05    P/E N/A 
Day Low $0.05    EPS
Volume 5,570       

SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.53 --0 (-0%)
Previous Close $17.53    52 Week High $63.73 
Open $17.53    52 Week Low $8.00 
Day High $17.53    P/E N/A 
Day Low $17.53    EPS $-5.69 
Volume 2,034